The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats
Abstract
The study was designed to compare the therapeutic efficacy of estrogen, the bisphosphonate risedronate (NE-58095), and PTH for restoration of lost bone mass in osteopenic, ovariectomized (OVX) rats. In addition, the skeletal effects of these single treatments were compared to those of concurrent treatments with PTH + estrogen or PTH + NE-58095. OVX rats were untreated for the first 4 weeks postovariectomy to allow for the development of moderate tibial osteopenia. These animals were then subjected to the various treatments for periods of 5, 10, and 15 weeks. Their proximal tibiae were processed undecalcified for quantitative bone histomorphometry. Treatment of osteopenic OVX rats with estrogen or NE-58095 alone depressed bone turnover and prevented additional cancellous bone loss from occurring during the treatment period. However, these therapeutic agents failed to restore lost bone in OVX rats to control levels. In contrast, OVX rats treated with PTH alone exhibited a marked stimulation of bone formation which resulted in augmentation of cancellous bone mass to a level 2-fold greater than that of vehicle-treated control rats. Concurrent treatment of OVX rats with PTH + estrogen as well as PTH + NE-58095 also effectively reversed cancellous osteopenia in OVX rats, but did not appear to be more beneficial to the estrogen-deplete skeleton than treatment with PTH alone. The results indicate that PTH is a powerful stimulator of bone formation and completely restores lost cancellous bone in osteopenic OVX rats. Furthermore, the bone anabolic effects of PTH are much more pronounced than those of estrogen or bisphosphonates. These findings in an animal model of estrogen depletion provide support for PTH as a potentially effective treatment for oophorectomized and postmenopausal women with established osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ovariectomized rat model of postmenopausal bone loss
Kalu, D. N. (1991) · Bone and Mineral · doi:10.1016/0169-6009(91)90124-i · Cited by 1,361
Storm, T., Thamsborg, G., Steiniche, T., Genant, H. K., & Sorensen, O. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221803 · Cited by 935
Reeve, J., Meunier, P. J., Parsons, J. A., Bernat, M., Bijvoet, O. L., Courpron, P., Edouard, C., Klenerman, L., Neer, R. M., Renier, J. C., et al. (1980) · BMJ · doi:10.1136/bmj.280.6228.1340 · Cited by 582
Riggs, B. L., Seeman, E., Hodgson, S. F., Taves, D. R., & O'Fallon, W. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198202253060802 · Cited by 557
Temporal relationship between bone loss and increased bone turnover in ovariectomized rats
Wronski, T. J., Cintrón, M., & Dann, L. M. (1988) · Calcified Tissue International · doi:10.1007/bf02571317 · Cited by 501
Self-citationThe Aged Rat Model of Ovarian Hormone Deficiency Bone Loss*
KALU, D. N., LIU, C.-C., HARDIN, R. R., & HOLLIS, B. W. (1989) · Endocrinology · doi:10.1210/endo-124-1-7 · Cited by 374
Hock, J. M., & Gera, I. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070110 · Cited by 367
Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats
Wronski, T. J., Walsh, C. C., & Ignaszewski, L. A. (1986) · Bone · doi:10.1016/8756-3282(86)90683-6 · Cited by 316
Self-citationEffect of body weight on osteopenia in ovariectomized rats
Wronski, T. J., Schenk, P. A., Cintrón, M., & Walsh, C. C. (1987) · Calcified Tissue International · doi:10.1007/bf02555700 · Cited by 258
Self-citationCHRISTIANSEN, C., & RIIS, B. J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-836 · Cited by 242
Cited by
Bone grafts and biomaterials substitutes for bone defect repair: A review
Wang, W., & Yeung, K. W. K. (2017) · Bioactive Materials · doi:10.1016/j.bioactmat.2017.05.007 · Cited by 1,938
Bone's mechanostat: A 2003 update
Frost, H. M. (2003) · The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology · doi:10.1002/ar.a.10119 · Cited by 1,535
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
Finkelstein, J. S., Hayes, A., Hunzelman, J. L., Wyland, J. J., Lee, H., & Neer, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035725 · Cited by 829
TURNER, R. T., RIGGS, B. L., & SPELSBERG, T. C. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-275 · Cited by 754
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Jilka, R. L. (2007) · Bone · doi:10.1016/j.bone.2007.03.017 · Cited by 720
Mechanisms of Action and Therapeutic Potential of Strontium in Bone
Marie, P. J., Ammann, P., Boivin, G., & Rey, C. (2001) · Calcified Tissue International · doi:10.1007/s002230010055 · Cited by 689
Osteoclast-derived activity in the coupling of bone formation to resorption
Martin, T. J., & Sims, N. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.004 · Cited by 659
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Silva, B. C., & Bilezikian, J. P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.03.005 · Cited by 557
Ishizuya, T., Yokose, S., Hori, M., Noda, T., Suda, T., Yoshiki, S., & Yamaguchi, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119491 · Cited by 349
Andreassen, T. T., Ejersted, C., & Oxlund, H. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.6.960 · Cited by 346
Dobnig, H. (1997) · Endocrinology · doi:10.1210/en.138.11.4607 · Cited by 322
Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
Finkelstein, J. S., Wyland, J. J., Lee, H., & Neer, R. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1703 · Cited by 265
Kostenuik, P. J., Capparelli, C., Morony, S., Adamu, S., Shimamoto, G., Shen, V., Lacey, D. L., & Dunstan, C. R. (2001) · Endocrinology · doi:10.1210/endo.142.10.8437 · Cited by 140
Kostenuik, P. J., Harris, J., Halloran, B. P., Turner, R. T., Morey-Holton, E. R., & Bikle, D. D. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.1.21 · Cited by 119
Osteoclasts secrete non-bone derived signals that induce bone formation
Karsdal, M. A., Neutzsky-Wulff, A. V., Dziegiel, M. H., Christiansen, C., & Henriksen, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.168 · Cited by 112
Mosekilde, L., Thomsen, J. S., Mackey, M. S., & Phipps, R. J. (2000) · Bone · doi:10.1016/s8756-3282(00)00375-6 · Cited by 78
Halloran, B. P., Bikle, D. D., Harris, J., Tanner, S., Curren, T., & Morey-Holton, E. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1068 · Cited by 45
Metadata
- Authors
- Wronski, T. J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1993-02-01
- Volume
- 132
- Issue
- 2
- Pages
- 823-831
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2025143421
- Cited by
- 290
- References
- 21
- FWCI
- 19.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.